SMTI (Sanara MedTech Inc. Common Stock) Stock Analysis - AI Report

Sanara MedTech Inc. Common Stock (SMTI) is a publicly traded Healthcare sector company. As of May 21, 2026, SMTI trades at $23.00 with a market cap of $200.60M and a P/E ratio of -5.28. SMTI moved +1.96% today. Year to date, SMTI is -2.38%; over the trailing twelve months it is -25.90%. Its 52-week range spans $16.05 to $39.08. Analyst consensus is buy with an average price target of $34.00. Rallies surfaces SMTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on SMTI?

Rallies AI research for SMTI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

SMTI Key Metrics

Key financial metrics for SMTI
MetricValue
Price$23.00
Market Cap$200.60M
P/E Ratio-5.28
EPS$-4.36
Dividend Yield0.00%
52-Week High$39.08
52-Week Low$16.05
Volume0
Avg Volume0
Revenue (TTM)$103.12M
Net Income$-37.57M
Gross Margin92.71%

Latest SMTI News

SMTI Analyst Consensus

2 analysts cover SMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $34.00.

Common questions about SMTI

What is the AI research view on SMTI?
Rallies AI research for SMTI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for SMTI?
Rallies AI research for SMTI combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is SMTI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SMTI. It does not provide personalized investment advice.
SMTI

SMTI